The new app allows users to browse services, book IV therapy, manage appointments, purchase packages, and track wellness—all from their mobile device.
ROCHESTER HILLS, Mich., Nov. 22, 2024 /PRNewswire/ — purelyIV, a leader in mobile IV therapy services in Metro Detroit, has officially launched its new mobile app, designed to bring ultimate convenience to clients. Available on both iOS and Android platforms, the app allows users to easily book services, manage appointments, purchase packages, and track their wellness journey—all at their fingertips.
With a sleek, user-friendly design, the purelyIV app offers clients the ability to:
“We’re excited to introduce this app to our clients,” said Michael Boumansour, CEO of purelyIV. “Our goal has always been to make wellness more accessible and convenient. This app is the next step in creating an enhanced, client-centered experience.”
The purelyIV app is designed for clients with busy lifestyles who want to maintain their wellness routine with minimal hassle. Whether booking an IV therapy session or exploring new services, the app empowers users to take control of their wellness on the go.
The purelyIV mobile app is now available for download on the Apple App Store and Google Play Store.
For more information about purelyIV and its offerings, visit purelyiv.com.
Contact:
Michael Boumansour
***@purelyiv.com
Photos:
https://www.prlog.org/13049465
Press release distributed by PRLog
SOURCE purelyIV
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…